Healthcare Leader’s fourth roundtable, 'How ICBs can encourage patient trust', brings together system leaders and experts to discuss how the NHS will advance the use of patient data.
Healthcare Leader’s roundtables look at the core issues facing the new NHS leaders at integrated care boards (ICBs), the challenges they face, the solutions they’ve found and their plans for the future.
Clinical leaders from Leicester, Leicestershire and Rutland and the NHS Confederation joined experts from commissioning support units and the Ada Lovelace Institute to discuss issues around collecting, using and sharing patient data.
Editor Victoria Vaughan says: ‘Much of the strategy for future health and care relies on better use of patient data, but in order to maximise the wealth of information held by the NHS, patients must be assured of the security of their information and informed about how it is used. Leaders at our roundtable discuss the current challenges and the measures underway to tackle these issues.’
The roundtables also feature on our new ICB Hub, which highlights the latest developments in each NHS region along with key ICB facts. The next roundtable will cover NHS data.
In July 2022, clinical commissioning groups were dissolved, and their staff were transferred into ICBs. This change was made to shift the way of working from competition to collaboration and bring health and care together. The ICB aims are better health for everyone, better care for all, efficient use of NHS resources, and to enhance the NHS contribution to social and economic regeneration.
ICBs represent the NHS in the wider integrated care partnerships as part of the integrated care systems.
Healthcare Leader aims to support NHS system leaders in taking forward their strategies for the future of health and social care in their places and neighbourhoods.
For the opportunity to reach our audience of decision-makers across NHS integrated care systems (ICSs), including ICB leaders, through a variety of digital advertising options, please contact us today.